Literature DB >> 2467274

Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland.

P A Abrahamsson1, H Lilja.   

Abstract

Immunohistochemical identification of the most prevalent type of neuroendocrine (NE) cells in the human prostate gland can be made with polyclonal antisera against human thyroid-stimulating hormone (TSH). A TSH-like peptide was characterized by analysis of prostatic tissue homogenates with sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) electrophoresis followed by immunoblotting. A single protein band, with an apparent mass of about 32 kDa after reduction, was identified both with polyclonal antisera against human TSH and with a polyclonal antiserum raised against a synthetic peptide corresponding to the carboxyterminal part of the beta-subunit of human TSH. The TSH-like prostatic peptide identified here is, on the basis of its molecular mass and absence of immunoreactivity with an antiserum raised against a synthetic peptide representing the mid-portion of the beta-subunit of TSH, not identical with the pituitary beta-subunit of TSH. On the other hand, this 32 kDa prostatic peptide may have certain structural elements in common with the pituitary beta-subunit of TSH, since it is recognized both with polyclonal antisera against TSH and with an antiserum against the carboxyterminal part of the beta-subunit of TSH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467274     DOI: 10.1002/pros.2990140109

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Prostatic neuroendocrine tumor in multiple endocrine neoplasia Type 2B.

Authors:  B Goulet-Salmon; E Berthe; S Franc; S Chanel; F Galateau-Salle; M Kottler; J Mahoudeau; Y Reznik
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 2.  Neuroendocrine peptides in the prostate.

Authors:  P J Gkonos; A Krongrad; B A Roos
Journal:  Urol Res       Date:  1995

3.  Incidence of neuroendocrine cells in the seminal vesicles and the prostate--an immunohistochemical study.

Authors:  Hans Jörg Sommerfeld; Alan Wayne Partin; Jürgen Pannek
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 4.  Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.

Authors:  M A Noordzij; G J van Steenbrugge; T H van der Kwast; F H Schröder
Journal:  Urol Res       Date:  1995

5.  Neuroendocrine Cells of the Prostate Derive from the Neural Crest.

Authors:  Jaroslaw Szczyrba; Anne Niesen; Mathias Wagner; Petra M Wandernoth; Gerhard Aumüller; Gunther Wennemuth
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

6.  Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.

Authors:  Lei Yan; Zhaoquan Xing; Zhaoxin Guo; Zhiqing Fang; Wei Jiao; Xiaoyu Guo; Zhonghua Xu; Zhenghui Fang; Anders Holmberg; Sten Nilsson; Zhaoxu Liu
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

7.  Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells.

Authors:  Michael E Wright; Jimmy Eng; James Sherman; David M Hockenbery; Peter S Nelson; Timothy Galitski; Ruedi Aebersold
Journal:  Genome Biol       Date:  2003-12-23       Impact factor: 13.583

Review 8.  Prostate cancer stem cells.

Authors:  Hanna Romańska-Knight; Paul Abel
Journal:  Cent European J Urol       Date:  2011-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.